AAAAAA

   
Results: 1-19 |
Results: 19
CYCLOSPORINE IN THE TREATMENT OF AN UNUSUAL CASE OF JUVENILE SYSTEMIC-SCLEROSIS
Authors: ALMAYOUF SM SILVERMAN ED FELDMAN BM THORNER P LAXER RM
Citation: Sm. Almayouf et al., CYCLOSPORINE IN THE TREATMENT OF AN UNUSUAL CASE OF JUVENILE SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(4), 1998, pp. 791-793
ASSESSMENT OF MYOCARDIAL PERFUSION AND FUNCTION IN CHILDHOOD SYSTEMICLUPUS-ERYTHEMATOSUS
Authors: GAZARIAN M FELDMAN BM BENSON LN GILDAY DL LAXER RM SILVERMAN ED
Citation: M. Gazarian et al., ASSESSMENT OF MYOCARDIAL PERFUSION AND FUNCTION IN CHILDHOOD SYSTEMICLUPUS-ERYTHEMATOSUS, The Journal of pediatrics, 132(1), 1998, pp. 109-116
EARLY PREDICTORS OF POOR OUTCOME IN SYSTEMIC-ONSET JUVENILE RHEUMATOID-ARTHRITIS - A MULTICENTER COHORT STUDY
Authors: SPIEGEL LR SCHNEIDER R LANG BA BIRDI N SILVERMAN ED LAXER RM FELDMAN BM
Citation: Lr. Spiegel et al., EARLY PREDICTORS OF POOR OUTCOME IN SYSTEMIC-ONSET JUVENILE RHEUMATOID-ARTHRITIS - A MULTICENTER COHORT STUDY, Arthritis and rheumatism, 41(9), 1998, pp. 96-96
THE SLEDAI, SLAM AND BILAG ARE SENSITIVE MEASURES TO EVALUATE CLINICAL-CHANGE IN CHILDHOOD-ONSET SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
Authors: BRUNNER HI FELDMAN BM BOMBARDIER C SCHNEIDER R SILVERMAN ED
Citation: Hi. Brunner et al., THE SLEDAI, SLAM AND BILAG ARE SENSITIVE MEASURES TO EVALUATE CLINICAL-CHANGE IN CHILDHOOD-ONSET SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 41(9), 1998, pp. 1385-1385
MULTICENTER STUDY OF OUTCOME IN JUVENILE DERMATOMYOSITIS (JDM)
Authors: HUBER AM LANG B LEBLANC CMA BIRDI N MACNEIL J FELDMAN BM
Citation: Am. Huber et al., MULTICENTER STUDY OF OUTCOME IN JUVENILE DERMATOMYOSITIS (JDM), Arthritis and rheumatism, 41(9), 1998, pp. 1390-1390
PEDIATRIC RHEUMATOLOGY IN THE 21ST-CENTURY - WHERES THE COMMON-SENSE - REPLY
Authors: FELDMAN BM GIANNINI EH
Citation: Bm. Feldman et Eh. Giannini, PEDIATRIC RHEUMATOLOGY IN THE 21ST-CENTURY - WHERES THE COMMON-SENSE - REPLY, Journal of rheumatology, 24(9), 1997, pp. 1856-1856
INTRAVENOUS IMMUNOGLOBULIN THERAPY IN JUVENILE DERMATOMYOSITIS
Authors: ALMAYOUF SM FELDMAN BM LAXER RM SCHNEIDER R SILVERMAN ED
Citation: Sm. Almayouf et al., INTRAVENOUS IMMUNOGLOBULIN THERAPY IN JUVENILE DERMATOMYOSITIS, Arthritis and rheumatism, 40(9), 1997, pp. 658-658
DEVELOPMENT OF VALIDATED DISEASE-ACTIVITY AND DAMAGE INDEXES FOR THE JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHIES .1. PHYSICIAN, PARENT, ANDPATIENT GLOBAL ASSESSMENTS
Authors: RIDER LG FELDMAN BM PEREZ MD RENNEBOHM RM LINDSLEY CB ZEMEL LS WALLACE CA BALLINGER SH BOWYER SL REED AM PASSO MH KATONA IM MILLER FW LACHENBRUCH PA
Citation: Lg. Rider et al., DEVELOPMENT OF VALIDATED DISEASE-ACTIVITY AND DAMAGE INDEXES FOR THE JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHIES .1. PHYSICIAN, PARENT, ANDPATIENT GLOBAL ASSESSMENTS, Arthritis and rheumatism, 40(11), 1997, pp. 1976-1983
WHERES THE EVIDENCE - PUTTING CLINICAL SCIENCE INTO PEDIATRIC RHEUMATOLOGY
Authors: FELDMAN BM GIANNINI EH
Citation: Bm. Feldman et Eh. Giannini, WHERES THE EVIDENCE - PUTTING CLINICAL SCIENCE INTO PEDIATRIC RHEUMATOLOGY, Journal of rheumatology, 23(9), 1996, pp. 1502-1504
CLINICAL-SIGNIFICANCE OF SPECIFIC AUTOANTIBODIES IN JUVENILE DERMATOMYOSITIS
Authors: FELDMAN BM REICHLIN M LAXER RM TARGOFF I STEIN LD SILVERMAN ED
Citation: Bm. Feldman et al., CLINICAL-SIGNIFICANCE OF SPECIFIC AUTOANTIBODIES IN JUVENILE DERMATOMYOSITIS, Journal of rheumatology, 23(10), 1996, pp. 1794-1797
SEASONAL ONSET OF SYSTEMIC-ONSET JUVENILE RHEUMATOID-ARTHRITIS
Authors: FELDMAN BM BIRDI N BOONE JE DENT PB DUFFY CM ELLSWORTH JE LANG BA LAXER RM LEWKONIA RM MALLESON PN OEN KG PAQUIN JD ROSENBERG AM SCHNEIDER R SILVERMAN ED
Citation: Bm. Feldman et al., SEASONAL ONSET OF SYSTEMIC-ONSET JUVENILE RHEUMATOID-ARTHRITIS, The Journal of pediatrics, 129(4), 1996, pp. 513-518
THE ASCP PURSUES ALLIED HEALTH GRANTS
Authors: FELDMAN BM
Citation: Bm. Feldman, THE ASCP PURSUES ALLIED HEALTH GRANTS, Laboratory medicine, 27(12), 1996, pp. 796-797
SECRETORY PHOSPHOLIPASE-A2 (SPLA2) IN KAWASAKI-DISEASE AS A PREDICTIVE MARKER OF CORONARY-DISEASE
Authors: MUZAFFER MA LIN MKS FELDMAN BM BOMZE S MCCRINDLE B LAXER RM SCHNEIDER R SILVERMAN ED
Citation: Ma. Muzaffer et al., SECRETORY PHOSPHOLIPASE-A2 (SPLA2) IN KAWASAKI-DISEASE AS A PREDICTIVE MARKER OF CORONARY-DISEASE, Arthritis and rheumatism, 39(9), 1996, pp. 1246-1246
DEVELOPMENT OF AN ADVERSE EVENT INDEX FOR USE IN CLINICAL-TRIALS OF PHARMACOTHERAPIES IN PEDIATRIC RHEUMATIC DISEASES .1. DEVELOPMENT OF THE SYMPTOM DOMAIN
Authors: GAZARIAN M BOMBARDIER C IBANEZ D FELDMAN BM WRIGHT JG KOREN G
Citation: M. Gazarian et al., DEVELOPMENT OF AN ADVERSE EVENT INDEX FOR USE IN CLINICAL-TRIALS OF PHARMACOTHERAPIES IN PEDIATRIC RHEUMATIC DISEASES .1. DEVELOPMENT OF THE SYMPTOM DOMAIN, Arthritis and rheumatism, 39(9), 1996, pp. 1248-1248
PHYSICIAN GLOBAL ASSESSMENTS OF DISEASE-ACTIVITY (DA) AND DISEASE CHRONICITY (DC) IN JUVENILE DERMATOMYOSITIS (JDM) - VALIDATION AND CONTRIBUTING FACTORS
Authors: RIDER LG FELDMAN BM RENNEBOHM RM LINDSLEY CB REED AM ZEMEL LS BALLINGER SH BOWYER SL PEREZ ME LOVELL DJ PASSO MH WALLACE CA VOGELGESANG SA KATONA IM SUNDEL BP KREDICH DW MILLER FW LACHENBRUCH PA
Citation: Lg. Rider et al., PHYSICIAN GLOBAL ASSESSMENTS OF DISEASE-ACTIVITY (DA) AND DISEASE CHRONICITY (DC) IN JUVENILE DERMATOMYOSITIS (JDM) - VALIDATION AND CONTRIBUTING FACTORS, Arthritis and rheumatism, 39(6), 1996, pp. 22-22
MEASURING DISABILITY IN JUVENILE DERMATOMYOSITIS - VALIDITY OF THE CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE
Authors: FELDMAN BM AYLINGCAMPOS A LUY L STEVENS D SILVERMAN ED LAXER RM
Citation: Bm. Feldman et al., MEASURING DISABILITY IN JUVENILE DERMATOMYOSITIS - VALIDITY OF THE CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE, Journal of rheumatology, 22(2), 1995, pp. 326-331
HOW SHOULD EXCESS ADMISSION LABORATORY TEST UTILIZATION BE CURTAILED - PEDIATRICIANS PREFERENCES
Authors: FELDMAN BM STEPHENS D WANG EEL
Citation: Bm. Feldman et al., HOW SHOULD EXCESS ADMISSION LABORATORY TEST UTILIZATION BE CURTAILED - PEDIATRICIANS PREFERENCES, Clinical and investigative medicine, 18(6), 1995, pp. 502-509
TOWARDS A MORE ETHICAL CLINICAL-TRIAL DESIGN - THE RANDOMIZED PLACEBOPHASE DESIGN (RPPD)
Authors: FELDMAN BM SZALAI JP
Citation: Bm. Feldman et Jp. Szalai, TOWARDS A MORE ETHICAL CLINICAL-TRIAL DESIGN - THE RANDOMIZED PLACEBOPHASE DESIGN (RPPD), Arthritis and rheumatism, 38(9), 1995, pp. 146-146
DIAGNOSTIC USE OF B-CELL ALLOANTIGEN D8 17 IN RHEUMATIC CHOREA/
Authors: FELDMAN BM ZABRISKIE JB SILVERMAN ED LAXER RM
Citation: Bm. Feldman et al., DIAGNOSTIC USE OF B-CELL ALLOANTIGEN D8 17 IN RHEUMATIC CHOREA/, The Journal of pediatrics, 123(1), 1993, pp. 84-86
Risultati: 1-19 |